Institutional and Fund Ownership

SecurityPPHMP / Peregrine Pharmaceuticals, 10.50% Ser E Cumulative Convertible Preferred Stock
President & CEOKING STEVEN W
Institutional Owners2
Institutional Shares226,998
Outstanding Shares44,773,727 (as of 2017-07-31)
Related PPHM / Peregrine Pharmaceuticals, Inc.

Peregrine Pharmaceuticals, 10.50% Ser E Cumulative Convertible Preferred Stock (NASDAQ:PPHMP) has 2 institutional investors that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 226,998 shares. Major holders include Stafford John S Iii, and Ronin Capital, LLC.


Peregrine Pharmaceuticals, 10.50% Ser E Cumulative Convertible Preferred Stock (NASDAQ:PPHMP) ownership summary shows current positions in the company by institutions and funds, as well as latest changes in position size. Owners can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click an asterisk (*) to see the full transaction history.

File DateFormInvestor Opt Prev Shares Current Shares Change
(Percent)
Prev Value (x$1000) Current Value (x$1000) Change
(Percent)
2017-05-19 SC 13D/A Ronin Capital, LLC * 95,059 111,699 17.50
2017-07-14 SC 13D/A STAFFORD JOHN S III * 115,299
2017-08-14 13F-HR PERCEPTIVE ADVISORS LLC * 200,000 0 -100.00 4,342 0 -100.00
2017-04-28 13F-HR Burt Wealth Advisors * 600 0 -100.00 12 0 -100.00
CUSIP: 713661403